Objective: To analyze the efficacy and safety of the WOMEN CARE(SJ global, bucheon).
Methods: This study is conducted by randomized controlled trial of 20 patients with Women care(Tap water) and 22 patients with control group(Dressing with Povidone io...
Objective: To analyze the efficacy and safety of the WOMEN CARE(SJ global, bucheon).
Methods: This study is conducted by randomized controlled trial of 20 patients with Women care(Tap water) and 22 patients with control group(Dressing with Povidone iodine) from September 1, 2019 to Febrary 28, 2020 in Hanyang University Hospital. Each group patients were visited our center four times. At first visit(VISIT 1), patients were examed of STD 12 and cervical culture. About 7 days later(VISIT 2), they were visited and grouped by Women care or povidone iodine dressing by randomized selection. They were dressing by each method. After 2 days later(VISIT 3) from VISIT2, cervical culture was done. After 2 days later(VISIT4) from VISIT3, cervical culture was done finally.
Results: There were no significant differences in demographic and clinical characteristics between the two groups. We compared the results of cervical culture gram positive bacteria at VISIT 1 and VISIT3. The quantitative decrease of bacteria was seen the 6 patients of 20 patients in WOMEN CARE group. In the control group, The quantitative decrease of gram positive bacteria was seen the 5 patients of 22 patients.
Conclusion: By this study, there was no significant side effect of WOMEN CARE; Vaginal itching sensation, redness and burning sensation. We confirmed the safety and efficacy of the WOMEN CARE.